tiprankstipranks
Trending News
More News >
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
US Market

CASI Pharmaceuticals (CASI) Income Statement

Compare
448 Followers

CASI Pharmaceuticals Income Statement

Last quarter (Q3 2024), CASI Pharmaceuticals's total revenue was $7.79M, a decrease of -11.82% from the same quarter last year. In Q3, CASI Pharmaceuticals's net income was $-8.39M. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.54M$ 33.88M$ 43.11M$ 30.17M$ 15.14M
Gross Profit
$ 11.15M$ 20.05M$ 27.28M$ 17.61M$ 5.63M
Operating Expenses
$ 50.77M$ 45.13M$ 53.77M$ 52.89M$ 38.95M
Depreciation and Amortization
$ 2.33M$ 3.74M$ 2.42M$ 3.10M$ 3.23M
EBITDA
$ -34.87M$ -21.54M$ -24.07M$ -32.75M$ -31.35M
Operating Income
$ -39.62M$ -25.08M$ -26.49M$ -35.28M$ -33.31M
Other Income/Expenses
$ 1.55M$ -1.21M$ -10.94M$ -560.00K$ -14.20M
Pretax Income
$ -38.07M$ -26.29M$ -37.43M$ -35.84M$ -47.51M
Net Income
$ -39.26M$ -26.94M$ -39.41M$ -37.77M$ -62.57M
Per Share Metrics
Basic EPS
$ -2.56$ -2.02$ -2.89$ -2.78$ -5.66
Diluted EPS
$ -2.56$ -2.02$ -2.89$ -2.78$ -5.66
Weighted Average Shares Outstanding
15.34M 13.36M 13.65M 13.61M 11.05M
Weighted Average Shares Outstanding (Diluted)
15.34M 13.36M 13.65M 13.61M 11.05M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis